Venom: The Last Dance Starts Strong in China with $9.3M Opening Day, Potential $165M Global Debut

https://icaro.icaromediagroup.com/system/images/photos/16379424/original/open-uri20241023-18-1vxhy46?1729712494
ICARO Media Group
Entertainment
23/10/2024 19h34

**Sony's 'Venom: The Last Dance' Kicks Off Strong In China With $9.3M Opening Day**

Sony's 'Venom: The Last Dance' has made a significant impact on its initial release in international markets, achieving an impressive $9.3 million on its first day in China. This marks the highest opening day for a superhero film in the region since 'Spider-Man: Far From Home,' suggesting a promising five-day launch within the $30 million range.

Compared to recent Hollywood films, 'Venom: The Last Dance' has outperformed, although direct comparisons are tricky as other releases typically launch over a standard weekend. In the current climate, any film surpassing the $20 million mark at debut in China is considered a considerable success for studios. Early audience feedback on Maoyan has been positive, with the movie scoring a 9, though critical reviews are still awaited which could influence its performance in the coming days.

The predecessor, 'Venom: Let There Be Carnage,' did not premiere in China, contrasting with the first 'Venom' film, which debuted to an extraordinary $107.7 million (historical rates) and concluded with $269.2 million in total earnings (historical conversion), alongside a high social score of 9.1. Current projections from Maoyan estimate 'Venom: The Last Dance' to achieve an $82.5 million total run in China.

Globally, 'Venom: The Last Dance' was anticipated to open around $150 million with $85 million expected from international markets. However, with China's five-day forecast indicating strong performance, the international potential now appears to be climbing towards $165 million. Directed by Kelly Marcel, who co-wrote the screenplay with Tom Hardy, the film will continue to roll out in 90% of its planned markets by Friday, with France and Japan set to join the release soon after.

The views expressed in this article do not reflect the opinion of ICARO, or any of its affiliates.

Related